The effect of a locally tailored intervention on the uptake of preconception care in the Netherlands: a stepped-wedge cluster randomized trial (APROPOS-II study)

Autor: V. Y. F. Maas, M. Poels, E. Ista, L. F. Menge, K. L. H. E. Vanden Auweele, R. W. A. de Bie, D. J. de Smit, E. H. van Vliet-Lachotzki, A. Franx, M. P. H. Koster

Publikováno v: BMC Public Health, Vol 22, Iss 1, Pp 1-16 (2022)

Abstract Background The preconception period provides a window of opportunity for interventions aiming to reduce unhealthy lifestyle behaviours and their negative effect on pregnancy outcomes. This study aimed to assess the effectiveness of a locally

Externí odkaz: https://doaj.org/article/08d30f0d18c842fa93df40f137080135

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA)

Autor: G.A.P. Nieuwenhuijzen, R.A. Hellingman, Franchette W P J van den Berkmortel, S. Hovenga, H.M. Oosterkamp, T. van Dalen, Sabine C. Linn, E.J. van Dulken, Rudi M. H. Roumen, Maurice J.C. van der Sangen, R.C. van Doorn, M.O. den Boer, R. den Toom, Carolien H. Smorenburg, J.J.M. van der Hoeven, Aafke H. Honkoop, Irene E. G. van Hellemond, H. Potthoff, R. Koelemij, Frans L. G. Erdkamp, A. van Bochove, W.G. van Leeuwen-Breuk, R.J.B. Blaisse, A.M.T. van der Velden, Yvonne Kamm, E.J.C. Vriens, Judith R. Kroep, Erik W. Muller, W.J.B. Mastboom, R. van Hillegersberg, P.C. van der Velden, T. van Voorthuizen, Vivianne C. G. Tjan-Heijnen, J.M. Meerum Terwogt, M.M. Vleugel, A. Vos, J.J. Jansen, Jos J. E. M. Kitzen, G.S. Madretsma, R. Vree, J.K.S. Nuytinck, Luc J. A. Strobbe, J.H. van Dam, P.H.A. Nijhuis, Wilfred K. de Roos, P.P.J.B.M. Schiphorst, B. Jas, E.E.M. Schepers, Q. van Rossum-Schornagel, Petronella G. M. Peer, C.J. van Groeningen, J.G. Haasjes, M.J. Agterof, E.A. Kouwenhoven, Alexander L T Imholz, Caroline M. Seynaeve, M.A. Davidis-van Schoonhoven, M.A.J. de Roos, M.J.P.M. Govaert, J.M.A. Ketel, J.M.G.H. van Riel, M. Jagers, A.J. van Overbeeke, Aart Beeker, J.K. Maring, G.J. Veldhuis, J.W.S. Merkus, Maaike de Boer, Onno R. Guicherit, H.B.A.C. Stockmann, E. Janssens van Vliet, J. de Boer, D.F.S. Kehrer, I.E. Arntz, N.G.J. van Diemen, Koop Bosscha, Hiltje de Graaf, F.A.A. Valster, E.E.M. Weernink, C.T.A.M. van Rossum, M.A. van Dijk, B.C. Tanis, Astrid C P Swinkels, E.J.M. Siemerink, D.W. Sommeijer

Publikováno v: Tjan-Heijnen, V C G, van Hellemond, I E G, Peer, P G M, Swinkels, A C P, Smorenburg, C H, van der Sangen, M J C, Kroep, J R, De Graaf, H, Honkoop, A H, Erdkamp, F L G, van den Berkmortel, F W P J, de Boer, M, de Roos, W K, Linn, S C, Imholz, A L T, Seynaeve, C M & Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators 2017, ' Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA) : a randomised, phase 3 trial ', The Lancet Oncology, vol. 18, no. 11, pp. 1502-1511 . https://doi.org/10.1016/S1470-2045(17)30600-9
The Lancet Oncology, 18(11), 1502-1511
Lancet Oncology, 18, 11, pp. 1502-1511
LANCET ONCOLOGY, 18(11), 1502. Lancet Publishing Group
The Lancet Oncology, 18(11), 1502-1511. Lancet Publishing Group
Lancet oncology, 18(11), 1502-1511. Elsevier Science
Lancet Oncology, 18(11), 1502-1511. Lancet Publishing Group
Lancet Oncology, 18, 1502-1511

Item does not contain fulltext BACKGROUND: The effect of extended adjuvant aromatase inhibition in hormone receptor-positive breast cancer after sequential endocrine therapy of tamoxifen followed by an aromatase inhibitor for a 5-year treatment perio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::772ac93cab50bc31223c7dc7ba3cb291
https://doi.org/10.1016/s1470-2045(17)30600-9

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis

Autor: Caroline Seynaeve, E. A. van Vliet, G.J. Liefers, A. Sajet, Esther Bastiaannet, C.C. Engels, Hein Putter, Jms Bartlett, R. L. P. Van Vlierberghe, Vincent T.H.B.M. Smit, A. Charehbili, Peter J. K. Kuppen, C.J.H. van de Velde

Publikováno v: Breast Cancer Research and Treatment, 149(3), 587-596. Springer New York
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 149(3), 587-596

Evidence exists for an immunomodulatory effect of endocrine therapy in hormone receptor-positive (HR+ve) breast cancer (BC). Therefore, the aim of this study was to define the prognostic and predictive value of tumor immune markers and the tumor immu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7d5bc5260d9ee0ca5743e161f287c18
https://pure.eur.nl/en/publications/79060abb-441e-44aa-8cfb-3e76689389a9

Lutetium-labelled peptides for therapy of neuroendocrine tumours

Autor: Eric P. Krenning, W. W. de Herder, E. I. van Vliet, Dirk Jan Kwekkeboom, Saima Khan, Jaap J.M. Teunissen, Boen Liong Kam

Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 39, 103-112. Springer-Verlag

Treatment with radiolabelled somatostatin analogues is a promising new tool in the management of patients with inoperable or metastasized neuroendocrine tumours. Symptomatic improvement may occur with (177)Lu-labelled somatostatin analogues that have

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::105aa53d2020df823eca408211155219
https://doi.org/10.1007/s00259-011-2039-y

Bridging the gap: a new module for human water use in the Community Earth System Model version 2.2.1.

Autor: Taranu, Sabin I.¹ (AUTHOR) sabin.taranu@vub.be, Lawrence, David M.² (AUTHOR), Wada, Yoshihide^3,4 (AUTHOR), Tang, Ting^3,4 (AUTHOR), Kluzek, Erik² (AUTHOR), Rabin, Sam² (AUTHOR), Yao, Yi¹ (AUTHOR), De Hertog, Steven J.^1,5 (AUTHOR), Vanderkelen, Inne^6,7,8 (AUTHOR), Thiery, Wim¹ (AUTHOR)

Publikováno v: Geoscientific Model Development. 2024, Vol. 17 Issue 20, p7365-7399. 35p.